BOTTAI, DARIA
 Distribuzione geografica
Continente #
NA - Nord America 5.424
AS - Asia 2.341
EU - Europa 2.206
SA - Sud America 381
AF - Africa 125
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.483
Nazione #
US - Stati Uniti d'America 5.282
CN - Cina 750
SG - Singapore 740
IT - Italia 640
SE - Svezia 380
HK - Hong Kong 356
BR - Brasile 331
DE - Germania 309
AT - Austria 168
BG - Bulgaria 157
GB - Regno Unito 141
FI - Finlandia 132
VN - Vietnam 120
CA - Canada 104
TR - Turchia 102
RU - Federazione Russa 88
IN - India 78
FR - Francia 57
KR - Corea 50
CI - Costa d'Avorio 41
UA - Ucraina 29
JP - Giappone 27
BE - Belgio 24
AR - Argentina 20
SN - Senegal 20
BD - Bangladesh 18
ES - Italia 17
MX - Messico 17
PK - Pakistan 16
ZA - Sudafrica 16
IQ - Iraq 15
MA - Marocco 12
NL - Olanda 11
PL - Polonia 11
NG - Nigeria 10
SA - Arabia Saudita 10
CH - Svizzera 9
EG - Egitto 9
ID - Indonesia 9
EC - Ecuador 8
UZ - Uzbekistan 8
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
PA - Panama 6
PY - Paraguay 6
MY - Malesia 5
AL - Albania 4
DK - Danimarca 4
GR - Grecia 4
LT - Lituania 4
NP - Nepal 4
TW - Taiwan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
CO - Colombia 3
DO - Repubblica Dominicana 3
NZ - Nuova Zelanda 3
RO - Romania 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
IE - Irlanda 2
KW - Kuwait 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
MU - Mauritius 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.481
Città #
Woodbridge 631
Ashburn 576
Chandler 426
Fairfield 424
Ann Arbor 391
Singapore 387
Houston 363
Hong Kong 350
Santa Clara 313
Dallas 219
Seattle 180
Beijing 173
Shanghai 170
Wilmington 163
Sofia 157
Cambridge 138
Vienna 130
Munich 123
New York 122
Milan 111
Serra 109
Hefei 89
Boardman 83
Los Angeles 80
Ottawa 76
Izmir 75
Princeton 70
Lawrence 63
Medford 59
London 53
Chicago 51
Seoul 49
Des Moines 48
Helsinki 47
Bremen 46
Florence 43
Abidjan 41
Dong Ket 38
Nanjing 37
Pisa 36
Lancaster 31
Redondo Beach 30
Council Bluffs 28
Jacksonville 26
Frankfurt am Main 24
Brussels 23
Dearborn 23
Marseille 23
São Paulo 23
Tokyo 23
Buffalo 22
Hyderabad 22
Lappeenranta 22
Ho Chi Minh City 21
Istanbul 21
Redwood City 21
San Diego 21
Dakar 20
Nuremberg 20
Falls Church 19
The Dalles 17
Pune 16
Columbus 15
Kunming 15
Boulder 14
Fuzhou 14
Nanchang 14
Phoenix 14
Hanoi 13
Rome 13
Kent 12
Salt Lake City 12
Shenyang 12
Norwalk 11
Tampa 11
Turku 11
Guangzhou 10
Quanzhou 10
Belo Horizonte 9
Latina 9
Ogden 9
Tianjin 9
Bern 8
Changsha 8
Jiaxing 8
Jinan 8
Orem 8
San Francisco 8
San Jose 8
Tashkent 8
Brasília 7
Curitiba 7
Genoa 7
Hebei 7
Lagos 7
Paris 7
Toronto 7
Warsaw 7
Washington 7
Amman 6
Totale 7.606
Nome #
Maternal anthropometric variables and clinical factors shape neonatal microbiome 313
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 262
A CRISPR/Cas9-based strategy to simultaneously inactivate the entire ALS gene family in Candida orthopsilosis 228
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 224
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 216
Characterization of the Candida orthopsilosis agglutinin-like sequence (ALS) genes 215
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 202
Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids 198
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 193
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 191
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 191
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 191
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 184
A graphenic and potentiometric sensor for monitoring the growth of bacterial biofilms 184
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 183
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 181
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 180
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 178
Microbial biofilm monitoring by electrochemical transduction methods 175
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 173
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 171
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 171
Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guerin (BCG) 170
Strong Immunogenicity and Cross-Reactivity of Mycobacterium tuberculosis ESX-5 Type VII Secretion -Encoded PE-PPE Proteins Predicts Vaccine Potential 160
Mycobacterial PE, PPE and ESX clusters: Novel insights into the secretion of these most unusual protein families 158
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 156
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 153
Identification of a novel Mycobacterium bovis BCG secretion protein 152
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 151
The BCG strain pool: Diversity matters 151
Mycobacterium tuberculosis Exploits Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection 148
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria 147
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages 147
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 146
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 144
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 143
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 143
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 142
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to Bactericidal Activity of Human beta-Defensin 3 in Biological Fluids 141
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 141
CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection 138
Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis 137
The secretion antigen SA5K has a role in the adaptation of Mycobacterium bovis bacillus Calmette-Guérin to intracellular stresses and hypoxia 134
Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11 133
Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions 128
Mycobacterial Pathogenomics and Evolution 125
In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains 125
Emerging Biosensing Technologies towards Early Sepsis Diagnosis and Management 124
Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages 124
Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs 124
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 123
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 121
Genetic manipulation as a tool to unravel Candida parapsilosis species complex virulence and drug resistance: state of the art 121
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 118
Phage-Based Control of Methicillin Resistant Staphylococcus aureus in a Galleria mellonella Model of Implant-Associated Infection 115
Biosensing systems for the detection and quantification of methane gas 115
Proliferative response and antibody production against SA5K, a secretion protein of M. tuberculosis in healthy subjects and patients with tuberculosis 114
Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis 114
A label-free impedance biosensing assay based on CRISPR/Cas12a collateral activity for bacterial DNA detection 114
ESX/type VII secretion systems and their role in host-pathogen interaction 112
Systematic genetic nomenclature for type VII secretion systems 111
Pathogenicity in the tubercle bacillus: Molecular and evolutionary determinants 110
Identification and molecular cloning of a novel secretion antigen from Mycobacterium bovis BCG. 108
The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis 107
Type VII Secretion Systems in Gram-Positive Bacteria 107
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2 107
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection 106
Voltammetric sensing of trypsin activity using gelatin as a substrate 103
ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection 103
ESAT-6 secretion-independent impact of ESX-1 genes espF and espG 1on virulence of Mycobacterium tuberculosis 98
null 57
Human serum lipids affect Staphylococcus aureus sensitivity to phage infection 24
null 1
Totale 10.698
Categoria #
all - tutte 30.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 102 26 52 72 44 37 99
2021/2022805 17 50 31 47 121 120 25 41 51 30 57 215
2022/20231.383 168 203 119 174 133 185 6 107 202 4 68 14
2023/2024813 74 64 139 45 83 142 32 28 13 45 45 103
2024/20252.536 10 77 35 141 243 238 313 136 218 290 331 504
2025/20261.508 219 289 289 210 286 215 0 0 0 0 0 0
Totale 10.698